Ingemar Turesson

Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. (2007)

Turesson, Ingemar, Linet, Martha S, Bjorkholm, Magnus, Kristinsson, Sigurdur Y, Goldin, Lynn R, Caporaso, Neil E, ...

Abstract is not available

Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group. (2006)

Lenhoff, Stig, Hjorth, Martin, Westin, Jan, Brinch, Lorentz, Backstrom, Bengt, Carlson, Kristina, ...

Abstract is not available

Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation. (2006)

Lenhoff, Stig, Hjorth, Martin, Turesson, Ingemar, Westin, Jan, Gimsing, Peter, Wisloff, Finn, ...

Abstract is not available

International Staging System for Multiple Myeloma. (2005)

Greipp, Philip R, San Miguel, Jesus, Durie, Brian G M, Crowley, John J, Barlogie, Bart, Bladé, Joan, ...

Abstract is not available

High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation. (2004)

Nilsson, Therese, Lenhoff, Stig, Rylander, Lars, Höglund, Mattias, Turesson, Ingemar, Mitelman, Felix, ...

Abstract is not available

MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: Evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q). (2004)

Nilsson, Therese, Nilsson, Lars, Lenhoff, Stig, Rylander, Lars, Astrand-Grundström, Ingbritt, Strömbeck, Bodil, ...

Abstract is not available

A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences. (2003)

Nilsson, Thérèse, Höglund, Mattias, Lenhoff, Stig, Rylander, Lars, Turesson, Ingemar, Westin, Jan, ...

The cytogenetic features (ploidy, complexity, breakpoints, imbalances) were ascertained in 783 abnormal multiple myeloma (MM) cases to identify frequently involved chromosomal regions as well as a...

Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate. (2003)

Barbouti, Aikaterini, Ahlgren, Tomas, Johansson, Bertil, Höglund, Mattias, Lassen, Carin, Turesson, Ingemar, ...

Most chronic myeloid leukaemia (CML) patients are genetically characterized by the t(9;22)(q34;q11), generating the BCR/ABL1 fusion gene. However, a few CML patients with rearrangements of 9q34 and...

Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy. (2002)

Seidel, Carina, Lenhoff, Stig, Brabrand, Sigmund, Anderson, Gøran, Standal, Therese, Lanng-Nielsen, Johan, ...

Abstract is not available

Studies on multiple myeloma and related disorders with special reference to lymphoid cell markers / (1979)

Turesson, Ingemar.

Thesis (doctoral)--University of Lund, 1979.

Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States

Landgren, Ola, Gridley, Gloria, Turesson, Ingemar, Caporaso, Neil E., Goldin, Lynn R., Baris, Dalsu, ...

The age-adjusted incidence of multiple myeloma (MM) is 2-fold higher in African Americans than in whites. A few small studies have reported a higher prevalence of monoclonal gammopathy of...

Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin’s lymphomas among relatives of patients with chronic lymphocytic leukemia

Goldin, Lynn R., Björkholm, Magnus, Kristinsson, Sigurdur Y., Turesson, Ingemar, Landgren, Ola

Previous studies have shown increased familial risk for chronic lymphocytic leukemia. This study by Goldin and colleagues examines the risk of lymphoid cancer development in first degree relatives of...

Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance

Kristinsson, Sigurdur Y., Goldin, Lynn R., Björkholm, Magnus, Turesson, Ingemar, Landgren, Ola

Autoimmunity and risk for Hodgkin’s lymphoma by subtype

Kristinsson, Sigurdur Y., Landgren, Ola, Sjöberg, Jan, Turesson, Ingemar, Björkholm, Magnus, Goldin, Lynn R

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia patients: a population-based study in Sweden

Kristinsson, Sigurdur Y., Björkholm, Magnus, Goldin, Lynn R., McMaster, Mary L., Turesson, Ingemar, Landgren, Ola

A role for genetic factors in the etiology of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) is implicated based on prior findings from multiply affected families and small...

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma

Kristinsson, Sigurdur Y., Fears, Thomas R., Gridley, Gloria, Turesson, Ingemar, Mellqvist, Ulf-Henrik, Björkholm, Magnus, ...

Patients with multiple myeloma (MM) have an increased risk of deep venous thrombosis (DVT), particularly when treated with immunomodulatory drugs. Recently, 2 small hospital-based studies observed...

Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies

Kristinsson, Sigurdur Y., Goldin, Lynn R., Björkholm, Magnus, Koshiol, Jill, Turesson, Ingemar, Landgren, Ola

There are data to support a role for genetic and immune-related factors in the pathogenesis of lymphomas and plasma cell diseases. In this paper, the AUTHORS review relevant studies in Hodgkin’s...